At a glance
ClinicalIndex Comparison RecordN/ACompleted· 143 enrolled
Drug / intervention
Butyrate Formulation +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Butyrate Formulation and a Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
In Brief
A clinical study evaluating Butyrate Formulation, Butyrate + Polyphenol Formulation, and 1 other intervention for Gut Health. Completed, enrolled 143 participants across 1 site.
Detailed Summary
The purpose of this study is the assess the effectiveness and safety of a Butyrate formulation and a Butyrate + Polyphenol formulation on gut health, permeability and associated symptoms
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGut Health
CountriesUnited States
CollaboratorsCompound Solutions Inc.
Timeline
N/ACompletedFinished
202420252026
Enrollment StartOct 2023
First PostedMay 2024
Primary CompletionDec 2024
Study CompletionJun 2025
TodayJul 2026
First PostedMay 17, 2024
Enrollment StartOct 31, 2023
Primary CompletionDec 23, 2024
Study CompletionJun 18, 2025
TodayJul 1, 2026
Enrollment to primary: 1.1 yearsPosted 2.1 years ago
Interventions
Butyrate Formulationdietary
Butyrate Formulation capsule: Take daily
Butyrate + Polyphenol Formulationdietary
Butyrate + Polyphenol Formulation capsule: Take daily
Placebodietary
Placebo: Take daily